HMGB1 mediates cognitive impairment in sepsis survivors

Molecular Medicine

Volumn 18, Issue 6, 2012, Pages 930-937

  Chavan, Sangeeta S ^a   Huerta, Patricio T ^b   Robbiati, Sergio ^b   Valdes Ferrer, S I ^a   Ochani, Mahendar ^a   Dancho, Meghan ^a   Frankfurt, Maya ^c   Volpe, Bruce T ^d   Tracey, Kevin J ^a   Diamond, Betty ^d  

^a North Shore Long Island Jewish Res   (United States)

^b Immune and Neural Networks   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; HIPPOCAMPUS; HISTOLOGY; LEARNING DISORDER; MALE; MEMORY DISORDER; MOUSE; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERITONITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEPSIS; SURVIVOR;

ANIMALS; ANTIBODIES, NEUTRALIZING; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HMGB1 PROTEIN; MALE; MEMORY; MICE; MICE, INBRED BALB C; SEPSIS; SURVIVAL ANALYSIS;

EID: 84865203635     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00195     Document Type: Article

References (25)

1. Iwashyna TJ, Ely EW, Smith DM and Langa KM. (2010) Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 304:1787-94.
2. Perl TM, Dvorak L, Hwang T and Wenzel RP. (1995) Long-term survival and function after suspected gram-negative sepsis. JAMA. 274:338-45.
3. Quartin AA, Schein RM, Kett DH and Peduzzi PN. (1997) Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA. 277:1058-63.
4. Boomer JS, et al. (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 306:2594-605.
5. Angus DC. (2010) The lingering consequences of sepsis: a hidden public health disaster? JAMA. 304:1833-4.
6. Nathan C and Ding A. (2010) Nonresolving inflammation. Cell. 140:871-82.
7. Xiao W, et al. (2011) A genomic storm in critically injured humans. J. Exp. Med. 208:2581-90.
8. Angus DC, et al. (2007) Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit. Care Med. 35:1061-7.
9. Stellwagen D and Malenka RC. (2006) Synaptic scaling mediated by glial TNF-alpha. Nature. 440:1054-9.
10. Viviani B, et al. (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23:8692-700.
11. Yoshida T, et al. (2012) Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule. J. Neurosci. 32:2588-600.
12. Terrando N, et al. (2010) Tumor necrosis factoralpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc. Natl. Acad. Sci. U. S. A. 107:20518-22.
13. Terrando N, et al. (2010) The impact of IL-1 modulation on the development of lipopolysaccharide induced cognitive dysfunction. Crit Care. 14:R88.
14. Goldstein RS, et al. (2006) Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock. 25:571-4.
15. Yang H, et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 101:296-301.
16. Li J, et al. (2004) Recombinant HMGB1 with cytokine-stimulating activity. J. Immunol. Methods. 289:211-23.
17. Chang EH, Rigotti A and Huerta PT. (2009) Agerelated influence of the HDL receptor SR-BI on synaptic plasticity and cognition. Neurobiol. Aging. 30:407-19.
18. Irwin S. (1968) Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia. 1:222-57.
19. Rogers DC, et al. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome. 8:711-3.
20. Contet C, Rawlins JN and Deacon RM. (2001) A comparison of 129S2/SvHsd and C57BL/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice. Behav. Brain Res. 124:33-46.
21. Deacon RM and Rawlins JN. (2002) Learning impairments of hippocampal-lesioned mice in a paddling pool. Behav. Neurosci. 116:472-8.
22. DeGiorgio LA, et al. (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7:1189-93.
23. Eilam-Stock T, Serrano P, Frankfurt M and Luine V. (2012) Bisphenol-A impairs memory and reduces dendritic spine density in adult male rats. Behav. Neurosci. 126:175-85.
24. Wang H, et al. (2001) HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164:1768-73.
25. Ulloa L. (2011) The anti-inflammatory potential of selective cholinergic agonists. Shock. 36:97-8.